{"id":"W2340320857","doi":"10.1097/ico.0000000000000803","title":"Safety of Lifitegrast Ophthalmic Solution 5.0% in Patients With Dry Eye Disease","year":2016,"lang":"en","type":"article","venue":"Cornea","topic":"Ocular Surface and Contact Lens","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Allergan; Omeros Corporation; Valeant Pharmaceuticals International","keywords":"Medicine; Placebo; Discontinuation; Intraocular pressure; Adverse effect; Visual acuity; Ophthalmology; Tolerability; Dysgeusia; Population; Artificial tears; Anesthesia; Surgery; Internal medicine","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004998492,0.00007970755,0.0001532085,0.00005086922,0.00001417438,0.00000188059,0.00004024689,0.0000334726,0.00008621982],"category_scores_gemma":[0.00004157567,0.00004692671,0.0000396765,0.000093785,0.00004111811,0.00006544034,0.0000173612,0.00004828301,0.00005138622],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005644916,"about_ca_system_score_gemma":0.00007386292,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002431776,"about_ca_topic_score_gemma":0.0000113255,"domain_scores_codex":[0.9993997,0.00001950152,0.0001430184,0.0001412887,0.0001553794,0.000141153],"domain_scores_gemma":[0.999522,0.00001756723,0.00004959225,0.0002414807,0.00006957423,0.00009981999],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001285796,0.0001935343,0.9913139,0.00003017312,0.00001468445,0.00001530861,0.00002732762,6.80797e-7,0.0007647075,0.00004443081,0.000006154683,0.006303347],"study_design_scores_gemma":[0.003139525,0.0002333436,0.9955333,0.0003508628,0.0000361548,4.469889e-8,0.00001024263,0.0000167917,0.0003063443,0.00002118595,0.0002837032,0.00006850406],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9985026,0.00009993234,0.0003048224,0.0001902382,0.00005243674,0.0002333898,0.00002548826,0.00001429728,0.0005767815],"genre_scores_gemma":[0.9993028,0.0000162496,0.00006305105,0.00005062579,0.00001937136,0.00000452907,0.00002269893,0.00001176041,0.0005089269],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006234843,"threshold_uncertainty_score":0.1913616,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007535532079675399,"score_gpt":0.2216866028418226,"score_spread":0.2141510707621472,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}